— Know what they know.
Not Investment Advice
Also trades as: 200028.SZ (SHZ) · $vol 0M

000028.SZ SHZ

China National Accord Medicines Corporation Ltd.
1W: -1.2% 1M: -1.3% 3M: -0.5% YTD: -25.0% 1Y: -23.1% 3Y: -45.2% 5Y: -28.5%
¥19.66 ($2.93)
+0.29 (+1.50%)
 
SHZ · Healthcare · Medical - Distribution · Tech Score Strong Sell · Power 33 · ¥10.5B mcap · 186M float · 1.57% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥10.5B ($1.6B)
52W Range18.7-24.94
Volume1,736,751
Avg Volume2,917,661
Beta0.17
Dividend¥0.62
Analyst Ratings
No analyst coverage
Company Info
CEOZhaoxiong Lin
Employees39,449
SectorHealthcare
IndustryMedical - Distribution
IPO Date1993-06-08
Yizhi Pharmaceutical Building
Shenzhen, GD 518029
CN
86 755 2587 5140
About China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms